Omniose Awarded $3.6 Million Grant from NIH to Develop Vaccines against Klebsiella pneumoniae
Business Wire
BOSTON & ST. LOUIS--(BUSINESS WIRE)--Omniose, a company developing polysaccharide conjugate vaccines against serious bacterial..
BOSTON & ST. LOUIS--(BUSINESS WIRE)--Omniose, a company developing polysaccharide conjugate vaccines against serious bacterial..
WBZ-TV's Tiffany Chan reports.